Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Staszewski

Showing results (21-30 of 95) with videos related to

Pageof 10
Sort By:
Lancet (London, England)|September 12, 1987
HIV transmission from male after only two sexual contactsS Staszewski, E Schieck, S Rehmet, et al.
Antiviral Therapy|March 21, 2000
Nevirapine/didanosine/lamivudine once daily in HIV-1-infected intravenous drug usersS Staszewski, A Haberl, P Gute, et al.
Pharmacoeconomics|October 28, 1999
A prospective evaluation of the cost effectiveness of adding lamivudine to zidovudine-containing antiretroviral treatment regimens in HIV infection. European perspectiveL Lacey, M Youle, P Trueman, et al.
HIV Medicine|December 12, 2001
A simple, once-daily dosing regimen for treating HIV-1 infection in intravenous drug usersS Staszewski, A Haberl, A Carlebach, et al.
Klinische Wochenschrift|October 2, 1991
[Intestinal permeability in patients with acquired immunodeficiency syndrome (AIDS)]M Ott, B Lembcke, S Staszewski, et al.
Lancet (London, England)|April 11, 1987
HIV-2 (West Germany, 1984)A Werner, S Staszewski, E B Helm, et al.
Cancer Detection and Prevention|August 5, 2000
Cervical intraepithelial neoplasia in human immunodeficiency virus-positive patientsA Ahr, A Scharl, K Lütke, et al.
The Clinical Investigator|March 1, 1994
AIDS-free survival and overall survival in HIV infection: the new CDC classification system (1993) for HIV disease and AIDSB S Kamps, H R Brodt, S Staszewski, et al.
Deutsche Medizinische Wochenschrift (1946)|July 3, 1987
[Ciprofloxacin and imipenem in nocardiosis]P M Shah, G Just, S Staszewski, et al.
AIDS (London, England)|December 24, 1998
Rebound of HIV-1 viral load after suppression to very low levelsS Staszewski, V Miller, C Sabin, et al.
Pageof 10

Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|September 12, 1987
HIV transmission from male after only two sexual contactsS Staszewski, E Schieck, S Rehmet, et al.
Antiviral Therapy|March 21, 2000
Nevirapine/didanosine/lamivudine once daily in HIV-1-infected intravenous drug usersS Staszewski, A Haberl, P Gute, et al.
Pharmacoeconomics|October 28, 1999
A prospective evaluation of the cost effectiveness of adding lamivudine to zidovudine-containing antiretroviral treatment regimens in HIV infection. European perspectiveL Lacey, M Youle, P Trueman, et al.
HIV Medicine|December 12, 2001
A simple, once-daily dosing regimen for treating HIV-1 infection in intravenous drug usersS Staszewski, A Haberl, A Carlebach, et al.
Klinische Wochenschrift|October 2, 1991
[Intestinal permeability in patients with acquired immunodeficiency syndrome (AIDS)]M Ott, B Lembcke, S Staszewski, et al.
Lancet (London, England)|April 11, 1987
HIV-2 (West Germany, 1984)A Werner, S Staszewski, E B Helm, et al.
Cancer Detection and Prevention|August 5, 2000
Cervical intraepithelial neoplasia in human immunodeficiency virus-positive patientsA Ahr, A Scharl, K Lütke, et al.
The Clinical Investigator|March 1, 1994
AIDS-free survival and overall survival in HIV infection: the new CDC classification system (1993) for HIV disease and AIDSB S Kamps, H R Brodt, S Staszewski, et al.
Deutsche Medizinische Wochenschrift (1946)|July 3, 1987
[Ciprofloxacin and imipenem in nocardiosis]P M Shah, G Just, S Staszewski, et al.
AIDS (London, England)|December 24, 1998
Rebound of HIV-1 viral load after suppression to very low levelsS Staszewski, V Miller, C Sabin, et al.
Pageof 10